THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 7, 2026, is entered into by and between FIBROBIOLOGICS, INC., a Delaware corporation, (the “Company”) and Peak One Opportunity Fund, L.P., a Delaware limited partn...
HOUSTON, September 17, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeut...
This Securities Purchase Agreement (this “Agreement”) is dated as of September 15, 2026, between FibroBiologics, Inc., a Delaware corporation (the “Company”), and Hamid Khoja, an individual (the “Purchaser”).
